Sangani Hospitals Ltd
Incorporated in 2021, Sangani Hospitals is in the business of Hospital, Laboratory, and Pharmacy[1]
- Market Cap ₹ 80.5 Cr.
- Current Price ₹ 58.4
- High / Low ₹ 78.0 / 48.5
- Stock P/E 42.6
- Book Value ₹ 27.1
- Dividend Yield 0.00 %
- ROCE 9.97 %
- ROE 7.44 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 9.54% over last 3 years.
- Earnings include an other income of Rs.1.10 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|
| 4.20 | 11.66 | 12.24 | 16.80 | 19.10 | |
| 2.75 | 8.57 | 9.14 | 14.31 | 17.01 | |
| Operating Profit | 1.45 | 3.09 | 3.10 | 2.49 | 2.09 |
| OPM % | 34.52% | 26.50% | 25.33% | 14.82% | 10.94% |
| 0.00 | 0.03 | 0.82 | 1.57 | 1.10 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.06 | 1.07 | 0.28 | 0.59 | 0.76 |
| Profit before tax | 1.39 | 2.05 | 3.64 | 3.47 | 2.43 |
| Tax % | 25.18% | 24.88% | 25.55% | 25.07% | |
| 1.04 | 1.53 | 2.70 | 2.59 | 1.89 | |
| EPS in Rs | 2.63 | 1.53 | 1.96 | 1.88 | 1.38 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 59% |
| TTM: | 36% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 36% |
| TTM: | -44% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -19% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 10% |
| Last Year: | 7% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|
| Equity Capital | 3.95 | 9.99 | 13.78 | 13.78 | 13.78 |
| Reserves | 1.04 | 8.01 | 19.71 | 22.31 | 23.55 |
| 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 1.62 | 1.22 | 1.49 | 2.58 | 4.01 | |
| Total Liabilities | 6.64 | 19.22 | 34.98 | 38.67 | 41.34 |
| 0.86 | 11.87 | 12.67 | 13.16 | 13.24 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.81 | 0.84 | 0.82 | 12.21 |
| 5.78 | 6.54 | 21.47 | 24.69 | 15.89 | |
| Total Assets | 6.64 | 19.22 | 34.98 | 38.67 | 41.34 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| 2.25 | 3.31 | 2.39 | ||
| -12.84 | -1.11 | -1.07 | ||
| 11.45 | 12.42 | -2.26 | ||
| Net Cash Flow | 0.86 | 14.62 | -0.94 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Debtor Days | 203.36 | 60.73 | 53.38 | 51.71 |
| Inventory Days | 160.09 | 48.98 | 92.54 | 114.53 |
| Days Payable | 448.25 | 85.32 | 128.52 | 83.07 |
| Cash Conversion Cycle | -84.80 | 24.39 | 17.39 | 83.17 |
| Working Capital Days | 88.64 | 42.26 | 37.57 | 48.88 |
| ROCE % | 18.33% | 14.14% | 9.97% |
Documents
Announcements
-
Outcome of Board Meeting
14 November 2025 - Approved H1 results; invested Rs.11.29 crore in Sadbhavna; IPO proceeds fully utilised (₹808.78 lakh).
-
Structural Digital Database
30 October 2025 - SEBI PIT compliance certificate for quarter ended Sep 30, 2025; SDD maintained; two events captured; no non-compliance.
-
Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
30 October 2025 - Company exempt from filing Regulation 27 corporate governance report for quarter ended 30 Sep 2025.
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
14 October 2025 - Certificate under Reg 74(5): not applicable—all shares dematerialised; no remat/demat requests for quarter ended 30 Sep 2025.
-
Shareholders meeting
28 September 2025 - AGM Sept 27, 2025: all six resolutions passed — FY2025 accounts adopted, directors/auditors appointed, MOA object clause altered.
Business Overview:[1][2]
SHL is in the business of Hospitals, pathological laboratory and Pharmacy stores. It operates 2 hospitals viz. Sangani Hospital at Keshod, Gujarat, and Sangani Super Speciality Hospital, Veraval, Gujarat. It also operates 2 pathology laboratories and 2 medical stores.